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Abstract
Background: Nitric oxide (NO) synthesized by endothelial cells is known to be a potent vasodilator. It has been 
suggested that polymorphisms in endothelial nitric oxide synthase (eNOS) can affect the response of the vascular 
endothelium to increased oxidative stress. The objective of the present study was to determine the presence of G894T 
(rs1799983), intron-4 (27-bp TR) and -T786C (rs2070744) polymorphisms in the eNOS gene among the Colombian 
general population.
Results: Genotype and allele frequencies showed significant differences in their distribution. White, black and mixed 
populations were in HW equilibrium for the variants in 27-bp TR- and rs1799983, but the black population was in HW 
disequilibrium for rs2070744 (p < 0.001). Allele "T" of rs1799983 polymorphisms was more common in the white 
population (26,5%) than the others, while allele "C" of rs2070744 polymorphisms had a similar frequency in all 
populations, and the allele 4a from 27-bp TR was more frequent in the black population (26,2%) than the others. Similar 
differences were found when genotypes were analyzed.
Conclusion: The findings suggest that there is a substantial difference in the distribution of eNOS polymorphisms 
between different ethnic groups. These results could aid the understanding of inter-ethnic differences in NO 
bioavailability, cardiovascular risk, and response to drugs.
Background
Cardiovascular disease (CVD) comprises a group of com-
plex diseases that are highly prevalent worldwide, but
show marked variation according to ethno geographical
distribution [1]. Environmental and genetic factors con-
tribute to ethnic variation and susceptibility to CVD;
interethnic differences in disease patterns can be due to
environmental and/or genetic factors [2].
Nitric oxide (NO) plays a pivotal role in the regulation
of cardiovascular homeostasis. This highly reactive mole-
cule is produced in endothelial cells and platelets by
endothelial NO synthase (eNOS); it maintains basal vaso-
dilator tone, inhibits platelet aggregation, attenuates leu-
kocyte adhesion to the endothelium, and modulates
smooth muscle proliferation [3]. Given the importance of
NO for cardiovascular function, polymorphisms that
alter eNOS activity or its regulation are likely candidates
for studies examining the genetic variability of vascular
disease [4]. Three clinically relevant polymorphisms in
endothelial eNOS have been associated with many CVDs:
single nucleotide polymorphisms (SNPs), one in the pro-
moter region (T-786C) and the other in exon 7 (G894T),
and the variable number of tandem repeats (VNTR) in
intron 4 [5].
Inconsistent associations between these eNOS variants
and CVD have been found. One possible explanation for
the contrasting results is that such association studies
normally focus on the contributions of a single polymor-
phism to a specific clinical condition and may not detect
modest effects [6]. Furthermore, population stratifica-
tion, as a consequence of ethnic diversity, could decrease
the reproducibility of association studies and dilute the
power of case-control studies designed to identify genetic
risk factors for a disease, particularly when ethnic varia-
tions in allele frequencies in cases and controls are not
matched [7]. Reliable information regarding the distribu-
tion of eNOS variants in different ethnic populations is
required in order to improve the design of association
studies.
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The Colombian population is very heterogeneous as
result of extensive inter-ethnic crosses between people
from different continents such as Europeans, Africans
and autochthonous Amerindians [6]. This study was con-
ducted to examine the distribution of three clinically rele-
vant polymorphisms found in the eNOS gene in five
Colombian ethnic groups, and to estimate the haplotype
frequency in these groups.
Results
Nine hundred and seventeen people were interviewed
and 890 individuals were included in this study; 27 were
excluded (15 that were selected for convenience and 12
who did not agree to give a blood sample). Table 1 shows
the frequencies of genotypes and alleles according to the
region of origin, demonstrating a considerable difference
in the distribution of eNOS polymorphisms among dif-
ferent cities. The distributions of genotypes for each
polymorphism were in HW equilibrium, with the excep-
tion of the Tamá Paez Amerindian population in which
the rs1799983 and rs2070744 genotypes were in HW dis-
equilibrium (p < 0.001 in both cases).
Table 2 presents genotype and allele frequencies
according to ethnic background and demonstrates signif-
icant differences in their distribution. Owing to differ-
ences in the frequencies of alleles and genotypes between
both Amerindian populations studied (Tamá Paez and
Emberá), each group was analysed separately. White,
black and mixed populations were in HW equilibrium for
the variants in 27-bp TR and rs1799983, but the black
population was in HW disequilibrium for rs2070744 (p <
0.001).
There were considerable differences in allelic variants
between the ethnic groups analysed. Variant 298T
(rs1799983) was more common in the white population
(26.5%) than the others. The C variant (rs2070744) had a
similar frequency in the white, mixed and Tamá Paez
Amerindians, was less frequent in the black population
(14.2%), and had the lowest frequency in Emberá Amer-
indians (1.7%).
As figure 1 demonstrates, the allele rare "a" of the 27-bp
TR variable was most frequent in the black population
(26.2%) and had the lowest frequency in the Emberá
Amerindians (1.7%). The frequencies of the rarer alleles
(c, y) were less than 5% among all the populations (Table
2), except for allele "c" among the Tama Paez Amerindi-
ans, which had a frequency of 6.7%.
Similar differences were found when genotypes were
analysed; the homozygous rs1799983 variant was more
common among the white population than the mixed
population (6.8% and 2.2%, p = 0.004), and it was absent
in the black population (p = 0.001) and Amerindians (p =
0.06). The CC of rs2070744 variant was more frequent in
the white population, while black and mixed populations
had a similar frequency (table 2), and it was absent among
Amerindians. However, these differences were not statis-
tically significant.
Genotype 4aa of 27-bp TR was more frequent among
the black and the mixed populations. However, the only
significant difference was between the black and white
populations (p = 0.048, figure 1c). Is important to note
the high heterozygosity for this marker in blacks (0.42),
which doubles the frequency value reported in mixed and
exceeds with statistically significance the value in the
other populations.
The frequencies of the haplotypes considered were cal-
culated for the different ethnic groups (table 3). The most
common haplotype in all ethnic groups was G,T,4b, which
combines the wild-type variants of all three polymor-
phisms. This wild-type haplotype was present at the
highest frequency in the Emberá Amerindians (93.3%).
The second most common haplotype was G,T,4a, which
included the variable 4a from 27-bp TR and the wild-type
allele for the other polymorphisms. This haplotype was
present at a higher frequency among the black population
(20.7%) than the other groups analysed (Table 3). Two
haplotypes with high frequencies in the white population
were  T,C,4b  (14.2%) and T,T,4b  (11.4%), both of which
include the minor allele frequency "T" to the rs1799983
variant; the difference in frequency compared with the
other populations was statistically significant (p < 0.001).
The haplotypes Glu,C,4y and T,T,4y were not detected.
Linkage analysis between each pair of combinations
demonstrated specific associations between ethnic
groups. There is linkage disequilibrium (LD) between the
white and mixed populations for the three polymor-
phisms but not between the black and Emberá popula-
tions. LD was demonstrated among the Tamá Paez
Amerindians, between rs2070744 and rs1799983 and
between rs2070744 and 27-bp TR-. The relationship
among the three ethnic groups in which LD exists is pre-
sented in figure 2.
Discussion
There were marked differences in the distribution of the
eNOS variants, the frequency of the haplotypes examined
and in the association between the variables in the
Colombian ethnic groups analyzed.
Two studies have been published showing inter-ethnic
differences in the frequencies of these three eNOS poly-
morphisms, which are considered clinically relevant to
CVD. The first study concerned Caucasian, African
American and Asian populations residing in the USA [6];
the second was carried out in white and black popula-
tions from Brazil [8]. A third study, analysing 4055 Japa-
nese individuals, analyzed two of these polymorphisms
[9]. The frequency of the variable T298 (rs1799983)
among the white Colombian population and reported inSerrano et al. BMC Genetics 2010, 11:54
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other study was similar. However, the analysis of the
Black population shows significant differences; we found
no homozygous individuals for this allele in the Colom-
bian black population, while in USA African Americans
this frequency was 10.0%, and homozygous individuals
were present in Brazilian black and Japanese populations.
The inter-ethnic and geographical differences could
explain the high incidence and severity of hypertension
among African Americans [10,11].
Homozygous CC from the rs2070744 variant (promoter
region) has similar frequencies in black populations in
various studies, less than 5%. However, we found signifi-
cant differences among white populations; it is less fre-
quent in the Colombian (5.9%) than the USA (16.0%) and
Brazilian (15.0%) populations.
In the 27-bp TR variant, the genotype "aa" was present
at lower frequency in the black populations analysed than
the other study done in a Latin American populations
(4.1% vs. 12.5%).
The variants 4c and 4y were not present in Caucasian
North American and Brazilian populations, but were
present at a low frequency (0.2%) in the white Colombian
population. An allele that defined like "4d" that presents
three 27pb repetitions, one more than allele "4a", has
been reported in an Italian population but not in Latin
American populations and we found no evidence for it in
the present study [12].
Table 1: Genotype and allelic frequencies by place of recruitment
Place of recruitment p-value
Frequencies Bucaramanga 
(n = 140)
Pasto 
(n = 136)
Cartagena 
(n = 135)
Quibdó 
(n = 169)
Pereira 
(n = 141)
Neiva 
(n = 169)
Genotype frequencies
rs1799983 G, G 0.443 0.676 0.704 0.820 0.667 0.540 <0.001
G, T 0.457 0.309 0.267 0.180 0.312 0.410
T, T 0.100 0.015 0.030 - 0.021 0.050
rs2070744 T, T 0.571 0.684 0.563 0.777 0.525 0.511 <0.001
T, C 0.379 0.287 0.363 0.187 0.418 0.439
C, C 0.050 0.029 0.074 0.036 0.057 0.050
27-bp TR 4b, 4b 0.914 0.890 0.615 0.453 0.688 0.741
4b, 4a 0.086 0.096 0.311 0.403 0.298 0.209
4a, 4a - 0.070 0.030 0.043 0.014 0.014
4a, 4c - - 0.015 0.022 - - <0.001
4b, 4c - 0.070 0.030 0.065 - 0.022
4b, 4y - - - 0.014 - 0.014
4c, 4c - - - - - -
Allelic frequencies
rs1799983 G 0.675 0.838 0.837 0.910 0.823 0.752 <0.001
T 0.325 0.162 0.163 0.090 0.177 0.248
rs2070744 T 0.761 0.827 0.752 0.871 0.734 0.741 <0.001
C 0.239 0.173 0.248 0.130 0.266 0.259
27-bp TR 4b 0.957 0.938 0.781 0.694 0.837 0.871 <0.001
4a 0.043 0.059 0.200 0.255 0.163 0.112
4c - 0.004 0.019 0.043 - 0.011
4y - - - 0.007 - 0.007Serrano et al. BMC Genetics 2010, 11:54
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Comparing the results of this study with previous
reports suggests that there are inter-ethnic differences for
various polymorphisms of eNOS, based on the geograph-
ical origin of the ethnic group analysed [13].
The most common haplotype for each of the ethnic
groups analysed in this study includes the wild-type vari-
ants (Glu,T,4b) that have a high frequencies among
Emberá Amerindians (93.3%). A recent study concerning
a Latin American population presented similar results,
the highest frequency being present in Amerindian tribes
from the Brazilian Amazon compared with black and
white populations [14].
The next two most frequent haplotypes in the white
Colombian population are the T allele from the
rs1799983 variant and the C allele from the rs2070744
variant, both of which are in linkage disequilibrium in
this ethnic group. These findings suggest that the high
cardiovascular risk attributed to the rs2070744 SNP (pro-
moter region) [15] and the rs1799983 variant [16] in Cau-
casians could be due to the combined effect of these
variants on the expression of eNOS. Together with the
l o w  f r e q u e n c y  o f  v a r i a b l e  4 a  i n  t h i s  p o p u l a t i o n ,  t h e s e
results suggest that the C variable from the promoter
region could be more relevant than the 4a variant in Cau-
casians. In support of this hypothesis, Metzger et al. dem-
onstrated a lower prevalence of this haplotype in healthy
white males with a lower production of nitric oxide [17].
The rs1799983 SNP is the only analyzed variant found
in a coding region of the gene; several studies have shown
the functional effect of this substitution. The first approx-
Table 2: Genotype and allelic frequencies by ethnic group
Ethnic group
Frequencies White 
(n = 323)
Black 
(n = 145)
Mixed 
(n = 357)
Emberá 
(n = 30)
Tamá Paez 
(n = 30)
p-value
Genotype frequencies
rs1799983 G, G 0.536 0.828 0.658 0.933 0.567 <0.001
G, T 0.396 0.172 0.319 0.067 0.433
T, T 0.068 - 0.022 - -
rs2070744 T, T 0.570 0.759 0.574 0.967 0.533 <0.001
T, C 0.372 0.200 0.381 0.033 0.467
C, C 0.059 0.041 0.045 - -
27-bp TR 4b, 4b 0.820 0.434 0.737 0.967 0.700 <0.001
4b, 4a 0.164 0.421 0.221 0.033 0.200
4a, 4a 0.009 0.041 0.017 - -
4a, 4c - 0.021 0.060 - -
4b, 4c 0.003 0.069 0.017 - -
4b, 4y 0.003 0.014 0.003 - 0.033
4 c ,  4 c ---- 0 . 0 6 7
Allele frequencies
rs1799983 G 0.735 0.914 0.824 0.967 0.783 <0.001
T 0.265 0.086 0.176 0.033 0.217
rs2070744 T 0.754 0.859 0.773 0.983 0.767 <0.001
C 0.246 0.142 0.227 0.017 0.233
27-bp TR 4b 0.904 0.686 0.859 0.983 0.817
4a 0.093 0.262 0.130 0.017 0.100 <0.001
4c 0.002 0.045 0.010 - 0.067
4y 0.002 0.007 0.001 - 0.017Serrano et al. BMC Genetics 2010, 11:54
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imation was achieved through in vitro studies undertaken
by Teasuro et al. These authors used human cardiac and
endothelial cells transfected with the polymorphic vari-
ant T298 and found that the resulting protein was more
susceptible to cleavage by internal proteases and hence
rapidly inactivated, reducing the production of NO [18].
Individuals homozygous for T-rs1799983 could suffer a
rapid loss of the mature protein due to cleavage, which
would translate into a lower production and bioavailabil-
ity of NO [19].
However, subsequent study demonstrate that the
exchange of glutamate against aspartate at position 298 in
human eNOS does not alter the catalytic function of pro-
tein. Thus, this study suggested that the 298 G to T poly-
morphism affects endothelial NO synthesis through the
intracellular targeting and/or changes in the phosphory-
lation state of eNOS in vivo [20]. In support of this, it was
demonstrated that healthy pregnant women with T-
rs1799983 had a 21% reduction in flux-mediated vasodi-
latation, a response dependent on NO, compared with
women without the polymorphism [21]. A study analyzed
these three variants in Mexican Americans in relation to
the risk of cardiovascular-renal disease and demonstrated
that variations in T-rs1799983 are directly linked to car-
diovascular disease, altering the generation of NO [22].
Other studies have shown that the black Colombian
population has a higher heterozygosity to the 27-bp TR
variant than white or Amerindians populations. This
variant has been associated with an increased risk of
developing cardiovascular [21] and renal [22] diseases in
Figure 1 Prevalence of genotypes among ethnic groups. Panel A: rs1799983 (G894T). W: wildtype (allele G), M: mutation (allele T) B: rs2070744 
(T-786C). W: wildtype (allele T), M: mutation (allele C) C: 27-bp TR (VNTR) W: wildtype (allele 4b), M: mutation (allele 4a), Other: genotype minor fre-
quency (4a/4c, 4b/4c, 4b/4c, 4b/4y, 4c/4c).
Table 3: Estimated haplotype frequency by ethnic group
Haplotype Ethnic group
rs1799983 rs2070744 27-bp TR White 
(n = 323)
Black 
(n = 145)
Mixed 
(n = 357)
Emberá 
(n = 30)
Tamá Paez 
(n = 30)
G T 4b 0.6017 0.5366 0.6108 0.9333 0.6638
G T 4a 0.0362 0.2070 0.0749 0.0167
G C 4b 0.0457 0.0763 0.0803 0.0167
G C 4a 0.0487 0.0431 0.0487 0.0529
G T 4c 0.0439 0.0053 0.0500
G T 4y 0.0016 0.0069 0.0167
G C 4c 0.0016 0.0803
T C 4b 0.1422 0.0220 0.0874 0.1167
T C 4a 0.0080 0.0054 0.0047
T C 4c 0.0001 0.0167
T C 4y 0.0014
T T 4b 0.1145 0.0513 0.0801 0.0333 0.0362
T T 4a 0.0120 0.0012
T T 4c 0.0009 0.0009Serrano et al. BMC Genetics 2010, 11:54
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Page 6 of 8
African Americans. Results regarding the biological role
o f  t h i s  v a r i a n t  h a v e  b e e n  c o n t r a d i c t o ry;  s o m e  r e p o r t s ,
such as that by Zhang et al., indicate that carriers of the
mutated variants have low plasma levels of NO. This
could be caused by the presence of the 27-nt microRNA
acting as an endogenous molecule for the feedback regu-
lation of eNOS expression in human endothelial cells
[23,24]. However, these results have not been reproduced
in all studies [25,26]. This variant could act with another
functional variant in the regulatory region of eNOS as a
marker of linkage disequilibrium. In the Colombian pop-
ulation studied herein, this variant was found in linkage
disequilibrium with G894T and T-786C in the white and
mixed populations, and with T-786C in the Tamá Paez
native population. In the last one, Amerindian popula-
tions, present endogamy with relative frequency, that can
be cause of this LD, and in this case was difficult exclude
consanguineous subjects.
The results of this study demonstrate the frequency of
the alleles, genotypes and related haplotypes from three
eNOS polymorphisms in the Colombian population.
These polymorphisms are relevant as markers for cardio-
vascular risk in different populations worldwide in addi-
tion to patients with preeclampsia [27,17]. The ethnic
differences suggest that cases and controls should be
matched by ethnicity in future genetic association stud-
ies. In addition, the homozygosity frequency for rare
alleles in the three polymorphisms were different among
ethnic groups, and could serve as a basis for defining
sample sizes when investigating significant differences
between populations and estimating the effects of such
polymorphisms.
Conclusions
The present findings and those previously reported sug-
gest that there is a substantial difference in the distribu-
tion of eNOS genetic variants between different ethnic
groups. These results could help understanding of inter-
ethnic differences in NO bioavailability, CVD risk and
responses to medications.
Methods
Sample
The study was descriptive, transversal and population-
bas ed ,  ca rri ed  o u t  i n  u r ba n  c i t i e s  fr o m  s ix  C o l o m b ia n
regions identified as having different ethnical configura-
tions (Bucaramanga, Cartagena, Pasto, Quibdó, Pereira
and Neiva). In addition, it included members of two
Amerindian communities (Emberá from Chocó, near
Quibdó; and Tamá Paez from Huila, near Neiva). The
study was evaluated and approved by the ethical review
board from the Biomedical Research Centre at the Uni-
versidad Autónoma de Bucaramanga. All participants
signed an informed consent form.
Individuals from urban settings were selected at ran-
dom in a three-stage process to include at least 140 indi-
viduals from each city. All stages involved single sampling
using independent random number lists; in the first step,
a sample of blocks from urban maps were selected; in the
second step, houses were selected in a similar way; the
third stage selected one individual from each selected
household. The participants recruited were healthy males
and females aged between 18 and 44 years, who were
born and lived in the studied region.
A survey was conducted that concerned demographic
data, ethnic and familial backgrounds. Each person was
classified as white, black, Amerindian or mixed according
to skin colour, characteristics of hair and facial features.
Each person gave his/her approval for the ethnic classifi-
cation that was awarded, or gave their own ethnic classifi-
cation. All participants were invited to give a peripheral
blood sample for DNA extraction.
DNA extraction and genotyping
Blood was drawn from the antecubital vein into a blood
tube containing EDTA and samples were stored at -20°C
until DNA extraction. DNA was extracted using the
QIAamp DNA blood minikit (QIAGEN©, Hilden, Ger-
many). The G894T (rs1799983) polymorphism was geno-
typed by polymerase chain reaction-restriction fragment
length polymorphism (PCR-RFLP) using the following
primer pairs: 5'AGG AAA CGG TCG CTT CGA CGT
Figure 2 Linkage disequilibrium by ethnic group. Likelihood disequilibrium by pair-wise combinations of polymorphisms in three ethnic groups.Serrano et al. BMC Genetics 2010, 11:54
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GCT G 3' and 5'CCC CTC CAT CCC ACC CAG TCA
ATC C 3' [18]. PCR was performed for 35 cycles in a vol-
ume of 30 μL. Denaturation was carried out at 95°C,
annealing at 63°C, and a final extension at 72°C, for 45 s.
Ten microliters of each PCR product (151 bp) was sub-
jected to restriction digestion with 2 U Dpn II, which
cleaves the PCR product into fragments of 49 and 101 bp
in the presence of the T allele (corresponding to T298).
The digested samples were resolved by electrophoresis.
Genotypes for intron 4, 27-bp TR polymorphism were
determined by PCR using the primers 5'-AGG CCC TAT
GGT AGT GCC TTT-3' and 5'-TCT CTT AGT GCT
GTG GTC AC-3'. PCR was performed for 35 cycles in a
volume of 40 μL. The PCR reaction mixture was heated
to 94°C for four min for denaturation and underwent 35
cycles at 94°C for 30 s for denaturation, at 63°C for 30 s
for annealing, and at 72°C for one min for extension. Final
extension was conducted at 72°C for five min. PCR prod-
ucts were resolved by electrophoresis. Fragments of 447,
420, 393 y 339 bp correspond to the eNOS alleles 4c, 4b,
4a and 4y, which defined the presence of six, five, four
and two 27-bp repeats [6,12].
The T-786C (rs2070744) variant in the 5'-flanking
region was assessed by PCR amplification using the prim-
ers 5'-TGG AGA GTG CTG GTG TAC CCC A-3' and 5'-
GCC TCC ACC CCC ACC CTG TC-3' with the same
temperature cycles described for polymorphism in intron
4 [17]. The amplified products were digested with Msp I
for overnight at 37°C, producing fragments of 140 and 40
bp for the wild-type allele, or 90, 50, and 40 bp in case of
polymorphism variants. These fragments were analyzed
by electrophoresis. All genotyping was conducted anony-
mously. For quality control, 10% of the samples were sub-
jected to repeat PCR and genotyping, and no
discrepancies were detected.
Statistical analysis
Information was typed in duplicate in Epi info 2000 ver-
sion 3.2. Using this software, the genotype and allele fre-
quencies for each polymorphism in the ethnic groups and
regions were calculated. The statistical significance of the
differences was calculated using a chi square test, and a
value of p < 0.05 was used as the significance threshold.
The Hardy-Weinberg Equilibrium (HWE) of each of
the three polymorphisms for each region and ethnic
group was calculated with Arlequin software. In addition,
we estimated the frequencies of the possible haplotypes
and the presence of linkage disequilibrium in each ethnic
group. This software uses maximum likelihood processes
in all estimates.
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